Using chitosan-coated magnetite nanoparticles as a drug carrier for opioid delivery against breast cancer

References

• Abdalla MO, Aneja R, Dean D, Rangari V, Russell A, Jaynes J, Yates C, Turner T. 2010. Synthesis and characterization of noscapine loaded magnetic polymeric nanoparticles. J Magn Magn Mater. 322(2):190–196. doi: 10.1016/j.jmmm.2009.07.086.
   PubMed Web of Science ®Google Scholar
• Adan A, Kiraz Y, Baran Y. 2016. Cell proliferation and cytotoxicity assays. Curr Pharm Biotechnol. 17(14):1213–1221. doi: 10.2174/1389201017666160808160513.
   PubMed Web of Science ®Google Scholar
• Aggarwal M, Leser GP, Lamb RA. 2020. Repurposing papaverine as an antiviral agent against influenza viruses and paramyxoviruses. J Virol. 94(6):e01888-19. doi: 10.1128/JVI.01888-19.
   PubMed Web of Science ®Google Scholar
• Akin D, Yakar A, Gündüz U. 2015. Synthesis of magnetic Fe3O4‐chitosan nanoparticles by ionic gelation and their dye removal ability. Water Environ Res. 87(5):425–436. doi: 10.2175/106143014x14062131178673.
   PubMed Web of Science ®Google Scholar
• Assa F, Jafarizadeh-Malmiri H, Ajamein H, Vaghari H, Anarjan N, Ahmadi O, Berenjian A. 2017. Chitosan magnetic nanoparticles for drug delivery systems. Crit Rev Biotechnol. 37(4):492–509. doi: 10.1080/07388551.2016.1185389.
   PubMed Web of Science ®Google Scholar
• Goorbandi RG, Mohammadi MR, Malekzadeh K. 2020. Synthesizing efficacious genistein in conjugation with superparamagnetic FeO4 decorated with bio-compatible carboxymethylated chitosan against acute leukemia lymphoma. Biomater Res. 24:9. (1 doi: 10.1186/s40824-020-00187-2.
   PubMedGoogle Scholar
• Han Z, Meng L, Huang X, Tan J, Liu W, Chen W, Zou Y, Cai Y, Huang S, Chen A, et al. 2022. Inhibition of p38 MAPK increases the sensitivity of 5‑fluorouracil‑resistant SW480 human colon cancer cells to noscapine. Oncol Lett. 23(2):52. doi: 10.3892/ol.2021.13170.
   PubMed Web of Science ®Google Scholar
• Hemalatha FC. 2011. FT-Raman, FTIR spectra and normal co-ordinate analysis of isoquinoline. Int J Phys Appl. 3:83–90.
   Google Scholar
• Inada M, Shindo M, Kobayashi K, Sato A, Yamamoto Y, Akasaki Y, Ichimura K, Tanuma S-I. 2019. Anticancer effects of a non-narcotic opium alkaloid medicine, papaverine, in human glioblastoma cells. PLoS One. 14(5):e0216358. doi: 10.1371/journal.pone.0216358.
   PubMed Web of Science ®Google Scholar
• Iqbal J, Abbasi BA, Mahmood T, Kanwal S, Ali B, Shah SA, Khalil AT. 2017. Plant-derived anticancer agents: a green anticancer approach. Asian Pac J Trop Biomed. 7(12):1129–1150. doi: 10.1016/j.apjtb.2017.10.016.
   Web of Science ®Google Scholar
• Kohzadi S, Najmoddin N, Baharifar H, Shabani M. 2022. Functionalized SPION immobilized on graphene-oxide: anticancer and antiviral study. Diam Relat Mater. 127:109149. doi: 10.1016/j.diamond.2022.109149.
   PubMed Web of Science ®Google Scholar
• Labanca F, Ovesnà J, Milella L. 2018. Papaver somniferum L. taxonomy, uses and new insight in poppy alkaloid pathways. Phytochem Rev. 17(4):853–871. doi: 10.1007/s11101-018-9563-3.
   Web of Science ®Google Scholar
• Landino LM, Koumas MT, Mason CE, Alston JA. 2007. Modification of tubulin cysteines by nitric oxide and nitroxyl donors alters tubulin polymerization activity. Chem Res Toxicol. 20(11):1693–1700. doi: 10.1021/tx7001492.
   PubMed Web of Science ®Google Scholar
• Mary JS, Vinotha P, Pradeep AM. 2012. Screening for in vitro cytotoxic activity of seaweed, Sargassum sp. against Hep-2 and MCF-7 cancer cell lines. Asian Pac J Cancer Prev. 13(12):6073–6076. doi: 10.7314/apjcp.2012.13.12.6073.
   PubMedGoogle Scholar
• Nagini S. 2017. Breast cancer: current molecular therapeutic targets and new players. Anticancer Agents Med Chem. 17(2):152–163. doi: 10.2174/1871520616666160502122724.
   PubMed Web of Science ®Google Scholar
• Newcomb EW, Lukyanov Y, Schnee T, Ali MA, Lan L, Zagzag D. 2006. Noscapine inhibits hypoxia-mediated HIF-1α expression andangiogenesis in vitro: a novel function for an old drug. Int J Oncol. 28(5):1121–1130. doi: 10.3892/ijo.28.5.1121.
   PubMed Web of Science ®Google Scholar
• Ozlu B, Kabay G, Bocek I, Yilmaz M, Piskin AK, Shim BS, Mutlu M. 2019. Controlled release of doxorubicin from polyethylene glycol functionalized melanin nanoparticles for breast cancer therapy: part I. Production and drug release performance of the melanin nanoparticles. Int J Pharm. 570:118613. doi: 10.1016/j.ijpharm.2019.118613.
   PubMedGoogle Scholar
• Parcha PK, Sarvagalla S, Ashok C, Sudharshan SJ, Dyavaiah M, Coumar MS, Rajasekaran B. 2021. Repositioning antispasmodic drug Papaverine for the treatment of chronic myeloid leukemia. Pharmacol Rep. 73(2):615–628. doi: 10.1007/s43440-020-00196-x.
   PubMed Web of Science ®Google Scholar
• Peng J, Sengupta S, Jordan VC. 2009. Potential of selective estrogen receptor modulators as treatments and preventives of breast cancer. Anticancer Agents Med Chem. 9(5):481–499. doi: 10.2174/187152009788451833.
   PubMed Web of Science ®Google Scholar
• Prabhakara P, Koland M, Nm H, Ahmed MG. 2010. Preparation and evaluation of transdermal patches of papaverine hydrochloride. Int J Res Pharm Sci. 1(3):259–266.
   Google Scholar
• Qin H, Wang CM, Dong QQ, Zhang L, Zhang X, Ma ZY, Han QR. 2015. Preparation and characterization of magnetic Fe3O4–chitosan nanoparticles loaded with isoniazid. J Magn Magn Mater. 381:120–126. doi: 10.1016/j.jmmm.2014.12.076.
   Web of Science ®Google Scholar
• Reeder JG, Vogel VG. 2008. Breast cancer prevention. In: Advances in breast cancer management. 2nd ed; p. 149–64. Boston, MA: Springer.
   Google Scholar
• Rida PC, LiVecche D, Ogden A, Zhou J, Aneja R. 2015. The noscapine chronicle: a pharmaco‐historic biography of the opiate alkaloid family and its clinical applications. Med Res Rev. 35(5):1072–1096. doi: 10.1002/med.21357.
   PubMed Web of Science ®Google Scholar
• Sajadian S, Vatankhah M, Majdzadeh M, Kouhsari SM, Ghahremani MH, Ostad SN. 2015. Cell cycle arrest and apoptogenic properties of opium alkaloids noscapine and papaverine on breast cancer stem cells. Toxicol Mech Methods. 25(5):388–395. doi: 10.3109/15376516.2015.1045656.
   PubMed Web of Science ®Google Scholar
• Shan F, Shao Z, Jiang S, Cheng Z. 2016. Erlotinib induces the human non–small‐cell lung cancer cells apoptosis via activating ROS‐dependent JNK pathways. Cancer Med. 5(11):3166–3175. doi: 10.1002/cam4.881.
   PubMed Web of Science ®Google Scholar
• Shundo C, Zhang H, Nakanishi T, Osaka T. 2012. Cytotoxicity evaluation of magnetite (Fe3O4) nanoparticles in mouse embryonic stem cells. Colloids Surf B Biointerfaces. 97:221–225. doi: 10.1016/j.colsurfb.2012.04.003.
   PubMed Web of Science ®Google Scholar
• Taherian A, Esfandiari N, Rouhani S. 2021. Breast cancer drug delivery by novel drug-loaded chitosan-coated magnetic nanoparticles. Cancer Nano. 12(1):1–20. doi: 10.1186/s12645-021-00086-8.
   PubMed Web of Science ®Google Scholar
• Tomar R, Sahni A, Chandra I, Tomar V, Chandra R. 2018. Review of noscapine and its analogues as potential anti-cancer drugs. MROC. 15(5):345–363. doi: 10.2174/1570193X15666180221153911.
   Google Scholar
• Unsoy G, Yalcin S, Khodadust R, Mutlu P, Onguru O, Gunduz U. 2014. Chitosan magnetic nanoparticles for pH responsive Bortezomib release in cancer therapy. Biomed Pharmacother. 68(5):641–648. doi: 10.1016/j.biopha.2014.04.003.
   PubMed Web of Science ®Google Scholar
• Urbas K, Aleksandrzak M, Jedrzejczak M, Jedrzejczak M, Rakoczy R, Chen X, Mijowska E. 2014. Chemical and magnetic functionalization of graphene oxide as a route to enhance its biocompatibility. Nanoscale Res Lett. 9(1):656. doi: 10.1186/1556-276X-9-656.
   PubMedGoogle Scholar
• van der Meel R, Sulheim E, Shi Y, Kiessling F, Mulder WJ, Lammers T. 2019. Smart cancer nanomedicine. Nat Nanotechnol. 14(11):1007–1017. doi: 10.1038/s41565-019-0567-y.
   PubMed Web of Science ®Google Scholar
• Wulandari I, Santjojo D, Shobirin R, Sabarudin A. 2017. Characteristics and magnetic properties of chitosan-coated Fe3O4 nanoparticles prepared by ex-situ co-precipitation method. Rasayan J Chem. 10:1348–1358.
   Google Scholar
• Zare M, Sarkati MN. 2021. Chitosan‐functionalized Fe3O4 nanoparticles as an excellent biocompatible nanocarrier for silymarin delivery. Polym Adv Techs. 32(10):4094–4100. doi: 10.1002/pat.5416.
   Web of Science ®Google Scholar
• Zhang L, Zhang Z, Chen F, Chen Y, Lin Y, Wang J. 2016. Aromatic heterocyclic esters of podophyllotoxin exert anti-MDR activity in human leukemia K562/ADR cells via ROS/MAPK signaling pathways. Eur J Med Chem. 123:226–235. doi: 10.1016/j.ejmech.2016.07.050.
   PubMed Web of Science ®Google Scholar
• Zughaier S, Karna P, Stephens D, Aneja R. 2010. Potent anti-inflammatory activity of novel microtubule-modulating brominated noscapine analogs. PLoS One. 5(2):e9165. doi: 10.1371/journal.pone.0009165.
   PubMed Web of Science ®Google Scholar